Palladone (Hydromorphone Hydrochloride)

Hydromorphone hydrochloride, the active ingredient in Palladone, is an opioid analgesic presented as a unknown strength/unknown form for intravenous use. It is used to treat moderate to severe pain, particularly in patients who require continuous, long‑term opioid therapy such as those with cancer or after major surgery.

GNH USA supplies Palladone as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Palladone is an opioid analgesic that acts on the central nervous system to manage pain in several clinical settings. - Cancer‑related pain: provides strong analgesia for patients with malignant disease. - Post‑operative pain: helps control pain after major surgical procedures. - Severe chronic pain: used when other analgesics are insufficient for persistent severe pain.

Adverse reactions to Palladone can range from mild to life‑threatening and should be monitored during therapy.

Common Side Effects: - Nausea and vomiting: mild to moderate gastrointestinal upset. - Constipation: reduced bowel motility leading to hard stools. - Drowsiness: increased sedation or fatigue. - Dizziness: light‑headed sensation, especially when standing. - Pruritus: itching without rash. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing that can be fatal. - Severe hypotension: marked drop in blood pressure. - Opioid dependence or withdrawal: signs of addiction with prolonged use. - Adrenal insufficiency: impaired cortisol production. - Anaphylaxis: rare severe allergic reaction. - QT interval prolongation: potential cardiac rhythm disturbance.

When prescribing Palladone, clinicians should consider several safety measures to minimize risk. - Assess pain severity: confirm that opioid therapy is appropriate for the level of pain. - Evaluate patient history: screen for respiratory disorders, head injury, or substance abuse. - Monitor vital signs: watch for respiratory rate and blood pressure changes. - Adjust dose cautiously: titrate based on response and tolerability, especially in the elderly. - Educate on side effects: inform patients about constipation and the need for bowel regimen. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Hydromorphone may interact with other medications, altering its efficacy or safety profile.

Major Interactions (Avoid): - CNS depressants (e.g., benzodiazepines, barbiturates): may cause profound respiratory depression. - MAO inhibitors: can precipitate severe hypertension or serotonin syndrome. - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): increase hydromorphone plasma levels.

Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): may modestly raise opioid concentrations. - Anticholinergics: can worsen constipation. - Diuretics: may enhance hypotensive effects. - Alcohol: additive central nervous system depression. - Antihistamines: increase sedation risk.